Rimsys Regulatory Management Software
- 02/12/2021
- Series A
- $16,000,000
Rimsys is a world-leading provider of Regulatory Information Management (RIM) software for medical technology companies. It consolidates all the functions of regulatory affairs, making product registration, standards management, essential principles/GSPR, regulatory submissions, post market surveillance and regulatory intelligence easy. Developed specifically for medtech and catered to your company’s workflows, Rimsys is the first and only holistic RIM software platform on the market for regulatory affairs professionals to digitize, automate, and navigate the global regulatory landscape.
Contact us:
letschat@rimsys.io
- Industry Medical Equipment Manufacturing
- Website https://www.rimsys.io/
- LinkedIn https://www.linkedin.com/company/rimsys/about/
Related People
James Gianoutsos, MBAFounder
James Gianoutsos is a quality assurance and regulatory affairs professional who has a diverse background in the medical device, pharmaceutical and biologics industries. James’ professional experience includes the design, premarket approval, clinical trials, manufacturing, distribution and post-market surveillance of drug products and class I, II, and III devices. It also includes products in a variety of clinical applications including infant jaundice management, neonatal respiratory care, infant incubation, sleep therapy, management of respiratory insufficiency, surgical adhesive for internal use, surgical sealant for prevention of gastrointestinal leaks, and bone healing accelerants. James has extensive experience in establishing and maintaining quality management systems in accordance with FDA, ISO, cGMP, MDD, CMDCAS requirements and standards and has helped develop and submit multiple regulatory filings including Premarket Approvals (PMA), 510(k)s, Design Dossiers, Technical Files and INDs. James holds a Bachelor of Science in operations management as well as a Master of Business Administration (MBA) with a concentration in operations management and strategy from the University of Pittsburgh – Katz Graduate School of Business.